Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(3): 815-822
DOI: http://dx.doi.org/10.20546/ijcmas.2016.503.094


Community Acquired Pneumonia is not free from Complications-A Tertiary Care Hospital Scenario
A.V. Sowmya1*, G. Jayalakshmi2 and David Agatha2
1Department of Microbiology, Government Chengalpatttu Medical College, Chengalpattu, Tamilnadu, India
2Institute of Microbiology, Madras Medical College, Chennai, Tamilnadu, India
*Corresponding author
Abstract:

Pneumonia is one of the most common public health infectious disease and one of the major cause of morbidity and mortality in elderly and immunocompromised(IC) patients. The mortality rate increases considerably when pneumonia is associated with the development of complications. This study is conducted to identify the current patterns of Community Acquired Pneumonia (CAP) complications, associated IC states and to analyze its microbiological profile. Patients above 18 years presenting with signs and symptoms of pneumonia during the study period were included. Associated complication patterns were documented. Various respiratory samples were collected aseptically and processed according to Standard Operating Procedures. The isolated microbial agents and their antimicrobial susceptibility pattern were identified according to CLSI guidelines. Out of the total 150 patients in the study group, 19.99% of them presented with one of the complications of CAP. Diabetes mellitus (48%) was the most common associated IC state followed by hematological malignancies (18.66%). Most common complication is bacteremia (9.33%), followed by pleural effusion (6%). Complications are more common in patients with associated IC state (70%) than in patients who are immunocompetant (IP) (30%) with statistical significance. Multidrug Resistant organisms are more commonly associated with complications (73.33%). Methicillin Resistant Staphylococcus aureus (36.67%) and Klebsiella pneumoniae (30%) were the most common bacterial agents identified in association with pneumonia complications. With antibiotic therapy being the main stay of treatment in CAP and with definitive treatment patterns for associated complications, proper knowledge of host factors, currently prevailing complication patterns, etiological agents and their resistance pattern pave an effective way to formulate empirical antibiotic therapy.


Keywords: Community acquired pneumonia, Complications, Multidrug resistance
Download this article as Download

How to cite this article:

Sowmya, A.V., Jayalakshmi,  G.  and David Agatha. 2016. Community Acquired Pneumonia is not Free from Complications-A Tertiary Care Hospital ScenarioInt.J.Curr.Microbiol.App.Sci. 5(3): 815-822. doi: http://dx.doi.org/10.20546/ijcmas.2016.503.094